Enoch Chan
Sydney, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Heparanase gene deficiency suppresses atherosclerosis progression and enhances plaque stability in apolipoprotein E gene knockout mice with diabetes.
Journal: Clinical science (London, England : 1979)
Published: December 10, 2025
In vivo toxicological evaluation of 3-benzylideneindolin-2-one: antifungal activity against clinical isolates of dermatophytes.
Journal: BMC pharmacology & toxicology
Published: December 13, 2024
Remote, smart telemonitoring of COVID-19 survivors for early detection of deterioration in cardiac health (the PARTMO study).
Journal: Frontiers in medical technology
Published: November 25, 2024
Heparanase promotes the onset and progression of atherosclerosis in apolipoprotein E gene knockout mice.
Journal: Atherosclerosis
Published: September 27, 2023
Heparanase: A Novel Therapeutic Target for the Treatment of Atherosclerosis.
Journal: Cells
Published: September 20, 2022
Endothelial-transcytosed myeloperoxidase activates endothelial nitric oxide synthase via a phospholipase C-dependent calcium signaling pathway.
Journal: Free radical biology & medicine
Published: October 13, 2020
Myeloperoxidase: A versatile mediator of endothelial dysfunction and therapeutic target during cardiovascular disease.
Journal: Pharmacology & therapeutics
Published: May 11, 2020
Thermostable small-molecule inhibitor of angiogenesis and vascular permeability that suppresses a pERK-FosB/ΔFosB-VCAM-1 axis.
Journal: Science advances
Published: October 08, 2019
Excipient Interactions in Glucagon Dry Powder Inhaler Formulation for Pulmonary Delivery.
Journal: Pharmaceutics
Published: March 19, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026